Rosenberg J, Petrylak D, Van Der Heijden M, Necchi A, O'Donnell P, Loriot Y, Retz M, Perez-Gracia J, Bellmunt J, Grivas P, Joseph R, Fong L, Kadel E, Boyd Z, Nickles D, Frampton G, Bourgon R, Hegde P, Mariathasan S, Powles T. PD-L1 expression, Cancer Genome Atlas (TCGA) subtype, and mutational load as independent predictors of response to atezolizumab (atezo) in metastatic urothelial carcinoma (mUC; IMvigor210). Journal Of Clinical Oncology 2016, 34: 104-104. DOI: 10.1200/jco.2016.34.15_suppl.104.Peer-Reviewed Original Research